Compare ICCC & VTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICCC | VTIX |
|---|---|---|
| Founded | 1982 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.1M | 83.9M |
| IPO Year | 1995 | 2025 |
| Metric | ICCC | VTIX |
|---|---|---|
| Price | $10.32 | $0.52 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 6.2K | ★ 226.7K |
| Earning Date | 11-12-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 53.85 | ★ 58.99 |
| EPS | ★ 0.41 | N/A |
| Revenue | ★ $26,493,169.00 | $4,252,643.00 |
| Revenue This Year | N/A | $18.40 |
| Revenue Next Year | N/A | $267.43 |
| P/E Ratio | $25.29 | ★ N/A |
| Revenue Growth | ★ 51.64 | 18.44 |
| 52 Week Low | $4.52 | $0.53 |
| 52 Week High | $12.10 | $9.00 |
| Indicator | ICCC | VTIX |
|---|---|---|
| Relative Strength Index (RSI) | 52.11 | 21.46 |
| Support Level | $9.45 | N/A |
| Resistance Level | $10.76 | $1.26 |
| Average True Range (ATR) | 0.22 | 0.07 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 48.80 | 4.97 |
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.
Virtuix Holdings Inc pioneers movement in AI-generated worlds, both imaginary and real. The company is the creator of Omni, a brand of omni-directional treadmills that enable users to walk and run in 360 degrees inside virtual reality (VR) games, digital twins, and other applications. Its technology operates at the intersection of gaming, fitness, and enterprise VR. Its products include Omni Pro, Omni Arena, and Omni One. Its business integrates a consumer and enterprise VR hardware platform anchored by its flagship Omni One product with a defense-oriented simulation system, Virtual Terrain Walk (VTW), targeting next-generation immersive mission planning.